Compared with glipizide, long-term therapy with metformin leads to a reduction in major cardiovascular events in patients with type 2 diabetes….
Read More »Up and Down Dieting in Older Women Causes Heart Damage
Wake Forest University researchers report that older women who lose weight and gain it back again may be increasing their risk for heart disease….
Read More »Breast Cancer Survivors Have Higher Diabetes Incidence
According to the findings of a population-based observational study, postmenopausal breast cancer survivors have a modest but meaningful increase in the incidence of diabetes….
Read More »Higher Diabetes Risk for Relatives with Psychosis
Relatives of patients with schizophrenia are at higher risk of developing diabetes….
Read More »Diabetes vs. Cancer
People with type 2 diabetes who are diagnosed with cancer ignore their diabetes in favor of cancer treatment but uncontrolled high blood sugar weakens their immune systems and is more likely to kill them than cancer….
Read More »Microaneurysm Turnover Predicts Retinopathy Progression
Automated analysis of microaneurysm (MA) turnover predicted the development of clinically significant macular edema (CSME) among patients with mild nonproliferative diabetic retinopathy (MNDR)….
Read More »Improved Beta-cell Function with Gastric Bypass or Gastric Banding
Both laparoscopic gastric banding and Roux-en-Y bypass surgery improved beta-cell function and insulin sensitivity….
Read More »Gastric Bypass Surgery Doesn’t Cure Diabetes
Information coming from the largest community-based study of long-term diabetes outcomes after gastric bypass surgery shows that for mostpeople in the study, diabetes either never remitted after gastric surgery or relapsed within five years….
Read More »Psoriasis and Obesity Go Together in Children
Significantly more children with psoriasis present as overweight or obese compared with control patients without the inflammatory disease, according to a multicenter, cross-sectional, international study….
Read More »Retinopathy Improved with Ranibizumab
Researchers found that ranibizumab (Lucentis) may slow the progression of diabetic retinopathy….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.